What Is a CMT Blood Test and What Does It Show?

A CMT blood test doesn’t measure anything in your blood chemistry. It reads your DNA for the inherited gene changes that cause Charcot-Marie-Tooth disease, a common inherited nerve condition. A positive result can turn years of vague foot and walking problems into a definite diagnosis with a named type.1Muscular Dystrophy Association. Diagnosis – Charcot-Marie-Tooth Disease (CMT) – Diseases A negative result, though, leaves CMT still possible.2Charcot–Marie–Tooth Association. Diagnosing CMT And since CMT runs in families, one person’s result often becomes useful information for parents, siblings, and children.

What the Test Looks For in Your DNA

The sample is a tube of blood or a saliva swab, collected like any routine draw.1Muscular Dystrophy Association. Diagnosis – Charcot-Marie-Tooth Disease (CMT) – Diseases The lab then looks for the most common gene changes known to cause CMT.1Muscular Dystrophy Association. Diagnosis – Charcot-Marie-Tooth Disease (CMT) – Diseases CMT affects about 1 in 2,500, which makes it the most common inherited nerve disorder.3PubMed Central. Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease

The blood is only a source of DNA, which is the same in every cell of your body. You don’t need to fast or prepare, and a saliva swab works just as well as blood.

The single most common finding is the cause of CMT1A, the most common type. It comes from an extra copy of a stretch of chromosome 17 that holds the PMP22 gene.4PubMed Central. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies People with CMT1A carry three copies of PMP22 instead of the usual two.5PubMed. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies In one group of people with CMT type 1, about 9 in 10 had this extra copy.5PubMed. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies

The type matters because the lab searches different genes for each. Type 1 damages the nerves’ insulating coating and slows signals, while type 2 damages the nerve fiber itself. There is also an X-linked form, tied to the GJB1 gene, which passes down differently in men and women than other forms do.

A short list of genes explains most findable cases. Among people whose CMT was traced to a gene, three changes (PMP22, GJB1, MPZ) explained about 89% of the coating-damage type.6PubMed. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients In the type that damages the nerve fiber itself, GJB1, MFN2, and MPZ explained about 84%.6PubMed. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients

How Testing Is Done in Steps

For the coating-damage type, the PMP22 copy check usually comes first.7Highmark Commercial Medical Policy. Highmark Commercial Medical Policy Pennsylvania It looks only for the extra stretch of chromosome 17, so a negative result says nothing about the many other genes that can cause CMT. That’s why a negative first step leads to a gene panel, one test that reads many CMT genes at once, rather than to a conclusion that the cause isn’t genetic.8Blue Cross and Blue Shield of North Carolina. Genetic Testing for Diagnosis of Inherited Peripheral Neuropathies AHS – M2072 Typical panels include genes such as GJB1, MPZ, MFN2, GDAP1, and SH3TC2.8Blue Cross and Blue Shield of North Carolina. Genetic Testing for Diagnosis of Inherited Peripheral Neuropathies AHS – M2072

Newer sequencing can read whole sets of genes or even the entire genome.9PubMed. Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges If a panel comes back empty, wider sequencing may still find the cause.10PubMed Central. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease

A panel reads a chosen list of known CMT genes. Whole-genome testing reads nearly all of your DNA, including genes not yet tied to CMT. Bigger tests find more, but they also turn up more results nobody can interpret yet. Doctors choose based on your type and earlier results.

In practice, your neurologist or a genetic counselor orders the test, and you give one sample of blood or saliva. Results often take several weeks. A genetic counselor usually goes through the report with you.

What Positive, Negative, and Uncertain Results Mean

At one large CMT clinic, about two-thirds of people with CMT got a specific genetic diagnosis.12PubMed Central. Charcot Marie Tooth CMT Subtypes and Genetic Testing Strategies That leaves about one in three people with clear CMT and no gene identified.12PubMed Central. Charcot Marie Tooth CMT Subtypes and Genetic Testing Strategies Panels may not cover every known gene, and some CMT genes haven’t been discovered yet.2Charcot–Marie–Tooth Association. Diagnosing CMT

A positive result tells you which gene is involved, and so which type of CMT you have, but it can’t predict how severe your symptoms will become. Even within one family sharing the same gene change, one person may have mild foot problems while another has more marked weakness.

An uncertain result isn’t a diagnosis either way. Doctors can look at whether the change appears in relatives who have CMT symptoms and is absent in relatives who don’t. If it turns up only in affected relatives, that supports it being the cause; if unaffected relatives carry it, the picture becomes less clear. This works best with several relatives, and a genetic counselor helps decide who is worth testing. Even then, family patterns are one piece of evidence rather than proof, so the lab may still be unable to reclassify the change. Labs do revisit these changes as knowledge grows, so ask your clinic to recontact you if yours is updated.

If your result is negative but you have CMT symptoms, your diagnosis can still rest on symptoms and nerve tests. Ask whether a broader test is worth doing later. New genes are found regularly, so retesting years later can help.

When Doctors Order the Test

Early signs usually start in the feet: high arches, flat feet, or curled hammer toes.13MedlinePlus. Charcot-Marie-Tooth disease: MedlinePlus Genetics Trouble lifting the front of the foot causes foot drop, a high step, tripping, and ankle sprains.13MedlinePlus. Charcot-Marie-Tooth disease: MedlinePlus Genetics Slow-starting symptoms and relatives with similar problems make doctors think genetic.14PubMed Central. The genetics of Charcot–Marie–Tooth disease: current trends and future implications for diagnosis and management

Expect questions about when your foot problems began, since CMT usually creeps in over years rather than appearing suddenly. You’ll be asked about relatives with high arches, an odd gait, frequent ankle sprains, or a diagnosis they never fully understood, because milder cases in a family are easy to miss. The doctor will also ask about diabetes, alcohol use, and medicines that can harm nerves, since these point to other explanations.

The physical exam checks ankle strength, reflexes, and sensation in the feet, and looks at foot shape and how you walk. Weak or absent ankle reflexes together with weakness in the lower legs fit a long-standing nerve condition. The exam can’t name the type of CMT, which is why nerve tests and DNA testing follow.

Before genetic testing, doctors usually run standard blood tests for other causes of nerve damage.15PubMed. Laboratory Tests for Neuropathies: What to do and to Avoid These include blood counts, thyroid, kidney and liver checks, blood sugar and HbA1c, vitamin B12, and a protein test called immunofixation.15PubMed. Laboratory Tests for Neuropathies: What to do and to Avoid Diabetes or low B12 can mimic CMT and are treatable. This routine bloodwork returns fast, while the genetic test reads DNA and takes weeks. Both can come from the same visit, and a normal routine panel neither confirms nor excludes CMT.

A nerve conduction study uses small electrical pulses to measure how fast nerves carry signals. In CMT1A, arm nerve signals traveled about 20 meters per second, well below the roughly 50 or more typical of healthy nerves.16PubMed. Nerve conduction studies in Charcot-Marie-Tooth disease in a cohort from Turkey That speed helps decide which genes to test first.

Will Insurance Cover It

One major insurer covers a CMT gene panel when you have signs like foot drop, distal weakness, numbness, weak reflexes, or high arches.7Highmark Commercial Medical Policy. Highmark Commercial Medical Policy Pennsylvania Known causes like diabetic nerve damage or B12 deficiency must be excluded first.7Highmark Commercial Medical Policy. Highmark Commercial Medical Policy Pennsylvania If the coating-damage type is likely, a negative PMP22 check is required before a panel.7Highmark Commercial Medical Policy. Highmark Commercial Medical Policy Pennsylvania Coverage usually isn’t given if your family’s mutation is already known and a panel would be redundant.7Highmark Commercial Medical Policy. Highmark Commercial Medical Policy Pennsylvania Insurers generally approve a test when it is likely to change care, and they prefer the narrowest test that can answer the question.

To improve your odds, ask your doctor to document symptoms and nerve-test results. If a relative’s mutation is known, bring proof, which allows cheaper targeted testing. Ask the lab about prior authorization and self-pay prices.

If the test is denied, ask the insurer for the denial in writing so you can see which criterion it says wasn’t met. Often the fix is missing paperwork, such as a nerve test report or documentation of ruled-out causes, which your doctor’s office can send. A letter from a genetic counselor can strengthen an appeal. If a first appeal fails, many plans allow a second-level or independent review, so ask what yours offers.

What a Result Means for Your Family

Once a family’s gene change is known, relatives can be tested for that exact change.17RÄ«ga Stradiņš University. GJB1 Gene Analysis in Two Extended Families with X-Linked Charcot-Marie-Tooth Disease Some learn their status before any nerve exam.17RÄ«ga Stradiņš University. GJB1 Gene Analysis in Two Extended Families with X-Linked Charcot-Marie-Tooth Disease In one family, a father with no symptoms carried the same disease-causing change as his affected daughter.18PubMed Central. Rapid Identification of Pathogenic Variants in Two Cases of Charcot-Marie-Tooth Disease by Gene-Panel Sequencing

Most CMT1A is dominant, so each child of an affected parent has a 1 in 2 chance of inheriting it. Recessive types need a change from both parents. X-linked types usually affect men more than women. A genetic counselor can map the odds for your family.

Adults can decide for themselves, while testing healthy children is more debated and often depends on whether it would change their care. If a child already has tripping or foot shape changes, testing is more clearly useful.

For having children, a known change can be checked during pregnancy with tests on placenta or fluid samples.19PubMed. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques With IVF, embryos can be tested before transfer.3PubMed Central. Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease In one center, about half of transferred cycles led to a birth, with five healthy babies.3PubMed Central. Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease Some cycles had no unaffected embryos to transfer.3PubMed Central. Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease

Guilt about passing on a gene is common. Relatives may choose not to know, and that’s their right. Counselors help plan how to share results.

Genetic results become part of your medical record, and laws in some countries limit how health insurers can use them. Those protections often don’t extend to life, disability, or long-term care insurance, so some people review those policies before testing. A genetic counselor can explain which rules apply where you live.

What Happens After a Diagnosis

Care works best with a team: neurologist, genetic counselor, physical and occupational therapists, rehab doctor, orthotist, and orthopedic surgeon.20Muscular Dystrophy Association. Medical Management – Charcot-Marie-Tooth Disease (CMT) – Diseases Therapy may include gait and balance training, stretching, night splints, fall prevention, and braces.21PubMed Central. Management of Charcot–Marie–Tooth disease: improving long-term care with a multidisciplinary approach

A physical therapist usually assesses your strength, balance, and walking, then teaches stretching and strengthening matched to your type. An orthotist can fit ankle braces that lift the front of the foot, which often makes walking steadier and reduces tripping. Supportive shoes can also reduce ankle rolls and pressure on high arches.

In daily life, check your feet regularly for sores or blisters, since reduced feeling means injuries can go unnoticed. Clearing loose rugs and adding lighting helps, because weak ankles make tripping common. Some medicines can harm nerves, so tell every doctor you have CMT before starting a new drug.

No approved treatment yet fixes the gene cause. But treatments that quiet the extra PMP22 copy in CMT1A are close to human testing.22PubMed. Charcot-Marie-Tooth disease: a review of clinical developments and its management – What’s new in 2025? Early safety trials are testing small-molecule drugs and gene therapies.23PubMed Central. Clinical trials in Charcot-Marie-Tooth disorders: a retrospective and preclinical assessment A known type makes you eligible for matching trials. Keep a copy of your genetic report, register with patient groups’ registries, and ask your neurologist about trials for your type. Check that a trial lists your exact gene.

Researchers are also studying blood proteins, such as neurofilament light, that run higher in CMT and rise with severity.24PubMed. Plasma neurofilament light chain as a potential biomarker in Charcot-Marie-Tooth disease These aren’t standard tests yet and don’t diagnose CMT.